Physician profile
Aaron Jon Chokan
NPI 1700888401
$142,001.71
in general payments reported to CMS, 2019-2025
48 companies · $55K in 2025
The $55K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,611 · 2020: $1,967 · 2021: $3,671 · 2022: $3,212 · 2023: $46K · 2024: $29K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $107K · Travel and Lodging: $11K · Food and Beverage: $9,112 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Grant: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $107,234.81 |
| Travel and Lodging | $11,064.25 |
| Food and Beverage | $9,112.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Grant | $430.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $121,138.43 | 2019-2025 | |
| Restor3d, INC. | $4,506.61 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $4,253.49 | 2023-2025 | |
| Stryker Corporation | $3,032.03 | 2019-2024 | Citrefix, Prophecy, Actishield |
| Linvatec Corporation | $1,635.45 | 2022-2024 | Colink Plating System, Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $1,085.41 | 2019-2021 | |
| Organogenesis INC. | $1,079.05 | 2019-2025 | Cygnus Dual |
| Smith+Nephew, INC. | $755.79 | 2019-2024 | Pico, Evos, Smart Tsf |
| Rock Medical Orthopedics, INC. | $666.80 | 2020-2022 | |
| Integra Lifesciences Corporation | $428.21 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $381.78 | 2021-2025 | Portfolio, Apex 3d, Precision Mis Bunion |
| Kerecis Limited | $303.38 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Convatec INC. | $256.01 | 2020-2025 | |
| In2bones USA, LLC | $229.60 | 2021-2022 | |
| Solventum Corporation | $188.20 | 2025 | Activ.A.C., Prevena, V.A.C.Ulta |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $178.32 | 2021-2023 | Dalvance, Teflaro |
| Paratek Pharmaceuticals, INC. | $162.63 | 2020-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $152.51 | 2024-2025 | Purified Cortrophin Gel |
| Kci USA, INC. | $143.98 | 2020-2023 | Activ.A.C. |
| Acell, INC. | $125.90 | 2019-2020 | |
| Nevro Corp. | $120.19 | 2021-2024 | Senza |
| Medshape, INC. | $117.94 | 2022 | |
| Sanara Medtech INC. | $116.71 | 2024 | Celleraterx |
| Polarityte, INC. | $106.46 | 2019 | |
| Misonix INC | $86.75 | 2020 | |
| Ebi, LLC | $86.22 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Arteriocyte Medical Systems, INC. | $73.14 | 2021-2024 | Magellan |
| Depuy Synthes Sales INC. | $65.00 | 2020 | |
| Amgen INC. | $55.33 | 2024 | Krystexxa |
| Globus Medical, INC. | $49.50 | 2021 | |
| Horizon Therapeutics Plc | $39.98 | 2019-2020 | |
| Orthofix Medical, INC. | $39.82 | 2023-2025 | Physio-Stim |
| Dynasplint Systems INC. | $35.47 | 2021 | |
| Tactile Systems Technology INC | $31.65 | 2025 | Nimbl, Flexitouch Plus |
| Axogen | $29.66 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Kowa Pharmaceuticals America, INC. | $26.72 | 2022-2023 | Seglentis |
| Polynovo North America LLC | $23.68 | 2024 | Novosorb Btm |
| Averitas Pharma INC. | $23.57 | 2025 | Qutenza |
| Medtronic, INC. | $22.80 | 2025 | Inceptiv |
| Bioventus LLC | $21.45 | 2023 | Stimrouter Implantable Kit |
| Nexus Medical Technologies LLC | $20.44 | 2025 | |
| Triad Life Sciences INC. | $18.81 | 2022 | |
| Ibsa Pharma INC. | $18.57 | 2023 | Tirosint, Licart |
| Mimedx Group, INC. | $16.86 | 2024 | |
| Zyla Life Sciences, INC. | $16.77 | 2019 | |
| Wright Medical Technology, INC. | $12.65 | 2019 | |
| Merck Sharp & Dohme LLC | $11.11 | 2019 | |
| Osiris Therapeutics INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$56.97 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Chokan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.